Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease

International Journal of Clinical Pharmacy

Volumn 35, Issue 6, 2013, Pages 1218-1228

  Puspitasari, Hanni Prihhastuti ^a,b   Aslani, Parisa ^a   Krass, Ines ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AIRLANGGA UNIVERSITY   (Indonesia)

Author keywords

Australia; Awareness; Cardiovascular disease; Community pharmacist; Medication management; Secondary prevention

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; AWARENESS; CARDIOVASCULAR DISEASE; DIET; DRUG MONITORING; EXERCISE; FEMALE; GROUNDED THEORY; HUMAN; LIFESTYLE MODIFICATION; MALE; MIDDLE AGED; NORMAL HUMAN; PATIENT CARE; PATIENT COUNSELING; PATIENT MONITORING; PERCEPTION; PHARMACIST; PHARMACIST ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SCOPE OF PRACTICE; SECONDARY PREVENTION; SELF CARE; SEMI STRUCTURED INTERVIEW; SMOKING CESSATION; WEIGHT CONTROL; YOUNG ADULT;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; CARDIOVASCULAR DISEASES; COMMUNITY PHARMACY SERVICES; CONTINUITY OF PATIENT CARE; COUNSELING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEW SOUTH WALES; PHARMACISTS; PROFESSIONAL ROLE; SECONDARY PREVENTION; YOUNG ADULT;

EID: 84892763119     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-013-9854-0     Document Type: Article

References (45)

1. Australian Institute of Health and Welfare. Cardiovascular disease: Australian facts 2011. Cardiovascular disease series. Cat. no. CVD. Canberra: AIHW; 2011. ISBN 978-1-74249-130-1.
2. National Heart Foundation. Data and statistics (cited 2013 Mar 21). Available from: http://www.heartfoundation.org.au/informationfor-professionals/ data-and-statistics/Pages/default.aspx.
3. National Health Priority Action Council. National chronic disease strategy. Canberra: Australian Government Department of Health and Ageing; 2006. ISBN 0-642-82869-5.
4. World Health Organization. Prevention of cardiovascular disease: pocket guidelines for assessment and management of cardiovascular risk. Geneva: WHO Press; 2007. ISBN 978-92-4-154726-l0.
5. Ponniah A, Anderson B, Shakib S, Doecke CJ, Angley M. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther. 2007;32(4):343-52.
6. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569-82.
7. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770-81.
8. Machado M, Nassor N, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother. 2008;42(9):1195-207.
9. McConnell KJ, Denham AM, Olson KL. Pharmacist-led interventions for the management of cardiovascular disease: opportunities and obstacles. Dis Manag Health Outcomes. 2008;16(3):131-44.
10. Evans CD, Watson E, Eurich DT, Taylor JG, Yakiwchuk EM, Shevchuk YM, et al. Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review. Ann Pharmacother. 2011;45(5):615-28.
11. Amariles P, Sabater-Hernandez D, Garcia-Jlmenez E, Rodriguez-Chamorro MA, Prats-Mas R, Marin-Magan F, et al. Effectiveness of dader method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial. J Manag Care Pharm. 2012;18(4):311-23.
12. George J, McNamara K, Stewart K. The roles of community pharmacists in cardiovascular disease prevention and management. Australas Med J. 2011;4(5):266-72.
13. Pharmaceutical Society of Australia. Guidelines for pharmacists providing Home Medicines Review (HMR) services. Canberra: PSA; 2011 (cited 2013 Aug 18). Available from: http://www.psa. org.au/download/practice-guidelines/home- medicines-reviewservices. pdf.
14. Sweeny K. The pharmaceutical industry in Australia: working paper no. Pharmaceutical industry project working paper series. Melbourne: Centre for Strategic Economic Studies Victoria University of Technology; 2007 [cited 2013 Feb 1]. Available from: http://www.cfses.com.
15. Creswell JW. Qualitative inquiry and research design: choosing among five approaches. 3rd ed. Thousand Oaks: Sage Publications; 2013. ISBN 978-1-4129-9530-6.
16. Birk M, Mills J. Grounded theory: a practical guide. London: Sage Publications; 2010. ISBN 9781848609938.
17. Pharmaceutical Society of Australia. Guidelines for pharmacists providing medicines use review (MedsCheck) and diabetes medication management (Diabetes MedsCheck) services. Canberra: PSA; 2012 (cited 2013 Aug 18). Available from: http://www.psa. org.au/download/guidelines/3612-medscheck-guidelines-c.pdf.
18. National Health and Medical Research Council. Strengthening cardiac rehabilitation and secondary prevention for Aboriginal and Torres Strait Islander people: a guide for health professionals. Canberra: Australian Government NHMRC; 2005. ISBN 1864 962720.
19. National Stroke Foundation. Clinical guidelines for stroke management 2010. Melbourne: National Stroke Foundation of Australia; 2010. ISSBN0-978-0-9805933-3-4.
20. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Reducing risk in heart disease: an expert guide to clinical practice for secondary prevention of coronary heart disease. Melbourne: National Heart Foundation of Australia; 2012. ISBN 978-1-74345-016-1.
21. Fei G, Jiang X, Gui-lian W, Jia-hong W, Jin-song W, Jin-ming Y, et al. Community-wide survey of physicians' knowledge of cholesterol management. Chin Med J. 2010;123(7):884-9.
22. Adams OP, Carter AO. Diabetes and hypertension guidelines and the primary health care practitioner in Barbados: knowledge, attitudes, practices and barriers-a focus group study. BMC Fam Pract. 2010;11(96):1.
23. Sacco RL, Adams R, Albers GW, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/ American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention. Stroke. 2006;37(2):577-617.
24. Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:00-00 (cited 2011 Nov 30). Available from: http://circ.ahajournals.org.
25. El Hajj MS, Al Nakeeb RR, Al-Qudah RA. Smoking cessation counseling in Qatar: community pharmacists' attitudes, role perceptions and practices. Int J Clin Pharm. 2012;34(4):667-76.
26. McCaig D, Fitzgerald N, Stewart D. Provision of advice on alcohol use in community pharmacy: a cross-sectional survey of pharmacists' practice, knowledge, views and confidence. Int J Pharm Pract. 2011;19(3):171-8.
27. Grimes T, Duggan C, Gallagher P, Strawbridge J. Care of the stroke patient-communication between the community pharmacist and prescribers in the Republic of Ireland. Pharm World Sci. 2009;31(6):648-55.
28. Puspitasari HP, Aslani P, Krass I. A review of counseling practices on prescription medicines in community pharmacies. Res Soc Adm Pharm. 2009;5(3):197-210.
29. Guirguis LM. Mixed methods evaluation: pharmacists' experiences and beliefs toward an interactive communication approach to patient interactions. Patient Educ Couns. 2011;83(3):432-42.
30. Lenz TL, Stading JA. Lifestyle modification counseling of patients with dyslipidemias by pharmacists and other health professionals. J Am Pharm Assoc. 2005;45(6):709-13.
31. Hunt LM, Kreiner M, Brody H. The changing face of chronic illness management in primary care: a qualitative study of underlying influences and unintended outcomes. Ann Fam Med. 2012;10(5):452-60.
32. Australian Government Department of Health and Ageing and the Pharmacy Guild of Australia. Pharmacy practice incentives: programspecific guidelines. 2012. p. 10 (cited 2013 Mar 25).Available from: http://www.5cpa.com.au/5CPA/ Initiatives/PPI/Program-Specific-Guidelines/Program?Specific?Guidelines.page.
33. Oladapo AO, Rascati KL. Review of survey articles regarding medication therapy management (MTM) services/programs in the United States. J Pharm Pract. 2012;25(4):457-70.
34. Mak VS, Clark A, Poulsen JH, Udengaard KU, Gilbert AL. Pharmacists' awareness of Australia's health care reforms and their beliefs and attitudes about their current and future roles. Int J Pharm Pract. 2012;20(1):33-40.
35. Rosenthal MM, Breault RR, Austin Z, Tsuyuki RT. Pharmacists' self-perception of their professional role: insights into community pharmacy culture. J Am Pharm Assoc. 2011;51(3):363-7.
36. Al Hamarneh YN, Rosenthal M, McElnay JC, Tsuyuki RT. Pharmacists' perceptions of their practice: a comparison between Alberta and Northern Ireland. Int J Pharm Pract. 2012;20:57-64.
37. AbuRuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71-9.
38. Ibrahim A, Scott J. Community pharmacists in Khartoum State, Sudan: their current roles and perspectives on pharmaceutical care implementation. Int J Clin Pharm. 2012;35(2):236-43.
39. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533-43.
40. Pellegrino AN, Martin MT, Tilton JJ, Touchette DR. Medication therapy management services: definitions and outcomes. Drugs. 2009;69(4):393-406.
41. National Health Service Employers and the Pharmaceutical Services Negotiating Committee. Guidance on the medicines use review service. London: NHS Employers and PSNC; 2012 (cited 2013 Mar 22). Available from: http://www.nhsemployers.org/ PayAndContracts/CommunityPharmacyContract/ CPCFservice developments2011/MUR/Pages/MedicinesUseReviewsGuidance. aspx.
42. Cipolle RJ, Strand LM, Morley PC, eds. Pharmaceutical care practice: the patient-centered approach to medication management services. New York: McGraw-Hill; 2012. ISBN 978-0-07-175638-9.
43. Gadkari AS, Mott DA, Kreling DH, Bonnarens JK. Pharmacy characteristics associated with the provision of drug therapy services in nonmetropolitan community pharmacies. J Rural Health. 2009;25(3):290-5.
44. Haag JD, Stratton TP. Patient care services in rural Minnesota community pharmacies. J Am Pharm Assoc. 2010;50(4):508-16.
45. Xu KT, Borders TF. Characteristics of rural elderly people who bypass local pharmacies. J Rural Health. 2003;19(2):156-64.